Features of cardiac remodeling in sclerodermic lung lesions
https://doi.org/10.20862/0042-4676-2016-97-3-157-160
Abstract
Objective: to examine the relationship between structural and functional heart remodeling and sclerodermic lung disease.
Material and methods. The study involved 62 women: 21 with systemic sclerosis (SSC) (mean age 49,4±2,1 years) and 41 healthy women (mean age 45±1,7 years) (р=0,127). Examination and treatment of patients with SSC was performed according to the guidelines. Instrumental diagnostics included cardiac US, chest X-ray, pulmonary high-resolution computed tomography.
Results. SSC patients, as compared to control group, demonstrated significant increase of end-diastolic left ventricular size, septal thickness, left ventricular mass and mass index. End-diastolic and end-systolic left ventricular size was significantly greater in patients with diffuse pulmonary fibrosis than with basal pulmonary fibrosis.
Conclusion. Our data indicate significant changes in the structural and functional parameters of the heart in SSC and their relationship with the progression of pulmonary pathology.
About the Authors
A. N. Kharkova
South Ural State Medical University, ul. Vorovskogo, 64, Chelyabinsk, 454092, Russian Federation
Russian Federation
Extramural Postgraduate Student
Russian Federation
Extramural Postgraduate Student
A. V. Sineglazova
South Ural State Medical University, ul. Vorovskogo, 64, Chelyabinsk, 454092, Russian Federation
Russian Federation
MD, PhD, DSc, Professor of Department of Polyclinic Therapy and Clinical Pharmacology
Russian Federation
MD, PhD, DSc, Professor of Department of Polyclinic Therapy and Clinical Pharmacology
References
1. Guseva N.G. (ed.) Systemic scleroderma and pseudosclerodermic syndromes. Moscow: Meditsina; 1993 (in Russ.).
2. Dryazhenkova I.V. Diastolic dysfunction of the left ventricle in patients with systemic lupus erythematosus and systemic sclerosis. Klinicheskaya Meditsina. 2005; 7: 45–7 (in Russ.).
3. Ioannidis J.P., Vlachoyiannopoulos P.G., Haidich A.B. et al. Mortality in systemic sclerosis: An international meta-analysis of individual patient data. Am. J. Med. 2005; 118: 2–10.
4. Mazurov V.I. (ed.) Clinical rheumatology. St.-Petersburg: Foliant; 2005 (in Russ.).
5. Belenkov Yu.N., Mareev V.Yu., Ageev F.K. Epidemiological study of heart failure: The state of the question. Consilium Medicum. 2002; 3: 112–4 (in Russ.).
6. Vasyuk Yu.A. Possibilities and limitations of echocardiographic studies in evaluation remodeling of the left ventricle in heart failure. Serdechnaya Nedostatochnost'. 2003; 2: 197–210 (in Russ.).
7. Khripunova A.A., Pasechnikov V.D., Khripunova I.G. Morfo-functional condition of cardiovascular system, exchange of lipids and hemocoagulations parametres at patients with systemic sclerosis. Fundamental'nye Issledovaniya. 2012; 4 (2): 376–80 (in Russ.).
8. Devereux R., Reicheck N. Echocardiographic determination of left ventricular mass in man. Circulation. 1977; 55: 613–8.
9. De Groote P., Gressin V., Hachulla E. et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann. Rheum. Dis. 2008; 67: 31–6.
10. Allanore Y., Meune C., Vonk M.C. et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann. Rheum. Dis. 2010; 69: 218–21.
11. Avdeev S.N. Chronic obstructive pulmonary disease and cardiovascular disease: Mechanisms association. Pul'- monologiya. 2008; 1: 5–10 (in Russ.).
12. Sin D.D., Man S.F. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc. Am. Thorac. Soc. 2005; 8: 8–11.
Review
For citations:
Kharkova A.N., Sineglazova A.V. Features of cardiac remodeling in sclerodermic lung lesions. Journal of radiology and nuclear medicine. 2016;97(3):157-160. (In Russ.) https://doi.org/10.20862/0042-4676-2016-97-3-157-160
Views:
820
Email this article 